Valuation: Zai Lab Limited

Market Cap 2.7B 21.16B 2.41B 2.23B 2.02B 3.77B 256B 3.84B 26.78B 10.6B 134B 10.12B 9.91B 423B P/E 2026 *
-10.9x
P/E 2027 * -10.9x
Enterprise Value 2.24B 17.57B 2B 1.85B 1.67B 3.13B 213B 3.18B 22.24B 8.8B 111B 8.41B 8.23B 351B EV / Sales 2026 *
5.13x
EV / Sales 2027 * 4.2x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Zai Lab Limited

1 day-0.34%
1 week-4.41%
Current month-13.86%
1 month-11.01%
3 months+15.60%
6 months+0.97%
Current year+30.26%
1 week 16.71
Extreme 16.71
20.06
1 month 16.71
Extreme 16.71
21
Current year 12.31
Extreme 12.31
21.42
1 year 12.31
Extreme 12.31
21.42
3 years 10.56
Extreme 10.56
35.5
5 years 10.56
Extreme 10.56
83.3
10 years 10.56
Extreme 10.56
151.2
Manager TitleAgeSince
Chief Executive Officer 61 31/03/2014
Director of Finance/CFO 58 06/07/2023
President 62 30/11/2022
Director TitleAgeSince
Chairman 61 31/03/2014
Director/Board Member 83 31/12/2016
Director/Board Member 75 31/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-4.41% - - 2.7B
-2.54%+1.31%+54.27%+114.96% 1,135B
-1.42%+3.23%+38.56%+74.44% 635B
+0.16%+0.08%+25.29%+95.23% 505B
-0.31%+3.09%+44.14%+64.80% 378B
-1.34%-0.47%+66.04%+41.00% 358B
-0.68%+2.65%+22.98%+50.39% 295B
-1.20%+3.04%+2.33%+22.86% 266B
-1.79%+1.57%+50.56%+59.08% 237B
-0.73%-0.10%+29.02%+99.67% 193B
Average -1.02%+2.17%+37.02%+69.16% 444.85B
Weighted average by Cap. -1.35%+2.66%+41.02%+79.75%

Financials

2026 *2027 *
Net sales 436M 3.42B 390M 360M 326M 610M 41.43B 621M 4.33B 1.72B 21.71B 1.64B 1.6B 68.44B 552M 4.33B 493M 455M 413M 772M 52.41B 785M 5.48B 2.17B 27.46B 2.07B 2.03B 86.58B
Net income -241M -1.89B -215M -199M -180M -337M -22.85B -342M -2.39B -946M -11.97B -903M -884M -37.74B -211M -1.66B -188M -174M -158M -295M -20.04B -300M -2.1B -830M -10.5B -792M -775M -33.1B
Net Debt -458M -3.59B -409M -378M -342M -640M -43.44B -651M -4.54B -1.8B -22.76B -1.72B -1.68B -71.76B -381M -2.99B -340M -314M -285M -533M -36.15B -541M -3.78B -1.5B -18.94B -1.43B -1.4B -59.71B
Projected Income Statement - Annual - Zai Lab Limited
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
23/10/26 HK$17.78 -0.34% 6,642,800
22/10/26 HK$17.84 -9.81% 4,445,700
21/10/26 HK$19.78 +4.88% 2,691,100
20/10/26 HK$18.86 +1.40% 2,340,500
16/10/26 HK$18.60 +3.62% 4,364,600
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Zai Lab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
24.03USD
Average target price
33.14USD
Spread / Average Target
+37.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Zai Lab Limited